Molecular Docking and Zone Inhibition Analysis of Fractionated Ethanol Extract of Zingiber officinale var. rubrum Against Candida albicans as Oral Antifungal
DOI:
https://doi.org/10.48048/tis.2024.7787Keywords:
Antifungal, Molecular docking, Red ginger, Good health, WellbeingAbstract
Ginger is a herb that can be used as an alternative medicine because it has anti-bacterial, antioxidant, anti-inflammatory, analgesic and antifungal properties. This study aims to identify the potency of red ginger ethanol extract against Candida albicans protein by using in silico and in vitro approaches. Several ginger-derived compounds were obtained from PubChem, while the target protein 4J14 was obtained from the Protein Data Bank (PDB) database. Prediction of Activity Spectra for Substances (PASS) Online was used to predict each compound’s biological function. Before molecular docking analysis, the 3D ligand site web server determined the binding site coordinates. PyRx was then used to perform molecular docking analysis on ginger compounds and the target protein 4J14, with fluconazole and posaconazole serving as controls. Additional analysis was used to identify amino acid residues in the complexes. The Chimera software was employed to describe protein compound complexes. The inhibitory zones of red ginger and fluconazole on fungal growth were determined in vitro. The molecular docking results showed that gamma-sitosterol had a more negative binding affinity (−9.6 kcal/mol) than fluconazole (−8.7 kcal/mol). Moreover, it affected the biological response of the target protein 4J14 or cytochrome 450, which is an essential protein in the fungal infection process. In vitro tests proved that a red ginger extract concentration of 15 mg/mL had antifungal potential. In silico and in vitro studies revealed that red ginger extract has the potential to be an antifungal agent.
HIGHLIGHTS
- Since there have been numerous studies on the content of red ginger compounds with essential oils that have been shown to have antifungal potential, the fractionation approach was used to extract active compounds in red ginger that are devoid of essential oils in order to determine the antifungal potential
- The biological response of cytochrome 450, also known as target protein 4J14, is impacted by gamma-sitosterol. This protein is crucial for the mechanisms involved in fungal infection
- An extract from red ginger exhibited the same antifungal potential as fluconazole, according to in vitro experiments
GRAPHICAL ABSTRACT
Downloads
Metrics
References
C Chamorro-Petronacci, A García-García, AI Lorenzo-Pouso, FJ Gómez-García, ME Padín-Iruegas, P Gándara-Vila, A Blanco-Carrión and M Pérez-Sayáns. Management options for low-dose methotrexate-induced oral ulcers: A systematic review. Medicina Oral, Patología Oral Y Cirugía Bucal 2019; 24, e181-e189.
T Mundula, F Ricci, B Barbetta, M Baccini and A Amedei. Effect of probiotics on oral candidiasis: A systematic review and meta-analysis. Nutrients 2019; 11, 2449.
J Liang, X Peng, X Zhou, J Zou and L Cheng. Emerging applications of drug delivery systems in oral infectious diseases prevention and treatment. Molecules 2020; 25, 516.
JDN Dias, CDS Silva, ARD Araújo, JMT Souza, PHDHV Júnior, WF Cabral, MDGD Silva, P Eaton, JRDSDA Leite, AM Nicola, P Albuquerque and I Silva-Pereira. Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells. Sci. Rep. 2020; 10, 10327.
ZH Khoury, T Vila, TR Puthran, AS Sultan, D Montelongo-Jauregui, MAS Melo and MA Jabra-Rizk. The role of Candida albicans secreted polysaccharides in augmenting Streptococcus mutans adherence and mixed biofilm formation: In vitro and in vivo studies. Front. Microbiol. 2020; 11, 307.
S Zhang, X Kou, H Zhao, KK Mak, MK Balijepalli and MR Pichika. Zingiber officinale var. rubrum: Red ginger’s medicinal uses. Molecules 2022; 27, 775.
A Herman and AP Herman. Herbal products and their active constituents used alone and in combination with antifungal drugs against drug-resistant Candida sp. Antibiotics 2021; 10, 655.
QQ Mao, XY Xu, SY Cao, RY Gan, H Corke, T Beta and HB Li. Bioactive compounds and bioactivities of ginger (Zingiber officinale Roscoe). Foods 2019; 8, 185.
RK Goel, D Singh, A Lagunin and V Poroikov. PASS-assisted exploration of new therapeutic potential of natural products. Med. Chem. Res. 2011; 20, 1509-14.
HS Budi, S Anitasari, NM Ulfa, MA Setiabudi, R Ramasamy, CZ Wu and YK Shen. Palmitic acid of Musa Paradisiaca induces apoptosis through caspase-3 in human oral squamous cell carcinoma. Eur. Rev. Med. Pharmacol. Sci. 2022; 26, 7099-114.
ME Prastiyanto, N Rohmah, L Efendi, R Arifin, FA Wardoyo, W Wilson, AH Mukaromah, SS Dewi and S Darmawati. Antifungal activities of the rhizome extract of five member Zingiberaceae against Candida albicans and Trichophyton rubrum. Biodiversitas J. Biol. Divers. 2021; 22, 1509-13.
J Talapko, M Juzbašić, T Matijević, E Pustijanac, S Bekić, I Kotris and I Škrlec. Candida albicans - the virulence factors and clinical manifestations of infection. J. Fungi 2021; 7, 79.
T Li, Q Hu, J Yang, N Zhang, N Liu and Q Liu. Topical Chinese herbal compound in the treatment of oral candidiasis: A systematic review and meta-analysis of randomized controlled trials. Heliyon 2023; 9, e13253.
A Herman and AP Herman. Herbal products and their active constituents used alone and in combination with antifungal drugs against drug-resistant Candida sp. Antibiotics 2021; 10, 655.
FE Agamah, GK Mazandu, R Hassan, CD Bope, NE Thomford, A Ghansah and ER Chimusa. Computational/in silico methods in drug target and lead prediction. Briefings Bioinformatics 2020; 21, 1663-75.
M Viceconti, F Pappalardo, B Rodriguez, M Horner, J Bischoff and FM Tshinanu. In silico trials: Verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products. Methods 2021; 185, 120-7.
A Bérard, O Sheehy, JP Zhao, J Gorgui, S Bernatsky, CSD Moura and M Abrahamowicz. Associations between low- and high-dose oral fluconazole and pregnancy outcomes: 3 nested case-control studies. Can. Med. Assoc. J. 2019; 191, E179-E187.
X Fan, M Xiao, D Zhang, JJ Huang, H Wang, X Hou, L Zhang, F Kong, SC Chen, ZH Tong and YC Xu. Molecular mechanisms of azole resistance in Candida tropicalis isolates causing invasive candidiasis in China. Clin. Microbiol. Infect. 2019; 25, 885-91.
M Shafiei, L Peyton, M Hashemzadeh and A Foroumadi. History of the development of antifungal azoles: A review on structures, SAR, and mechanism of action. Bioorg. Chem. 2020; 104, 104240.
N Mast, W Zheng, CD Stout and IA Pikuleva. Antifungal azoles: Structural insights into undesired tight binding to cholesterol-metabolizing CYP46A1. Mol. Pharmacol. 2013; 84, 86-94.
V Meylani, RR Putra, M Miftahussurur, S Sukardiman, FE Hermanto and A Abdullah. Molecular docking analysis of Cinnamomum zeylanicum phytochemicals against secreted aspartyl proteinase 4 - 6 of Candida albicans as anti-candidiasis oral. Results Chem. 2023; 5, 100721.
RK Veni and SS Meenambiga. In-silico analysis of endophytic fungal metabolites against secreted aspartic proteinase enzyme of Candida albicans. Res. J. Pharm. Tech. 2019; 12, 3495-500.
H Yousfi, S Ranque, JM Rolain and F Bittar. In vitro polymyxin activity against clinical multidrug-resistant fungi. Antimicrob. Resist. Infect. Contr. 2019; 8, 66.
JM Rybak, JF Muñoz, KS Barker, JE Parker, BD Esquivel, EL Berkow, SR Lockhart, L Gade, GE Palmer, TC White, SL Kelly, CA Cuomo and PD Rogers. Mutations in TAC1B: A novel genetic determinant of clinical fluconazole resistance in Candida auris. mBio 2020; 11, e00365-20.
Y Zhu, B O’Brien, L Leach, A Clarke, M Bates, E Adams, B Ostrowsky, M Quinn, E Dufort, K Southwick, R Erazo, VB Haley, C Bucher, V Chaturvedi, RJ Limberger, D Blog, E Lutterloh and S Chaturvedi. Laboratory analysis of an outbreak of Candida auris in New York from 2016 to 2018: Impact and lessons learned. J. Clin. Microbiol. 2020; 58, e01503-19.
MT Kalhoro, H Zhang, GM Kalhoro, F Wang, T Chen, Y Faqir and F Nabi. Fungicidal properties of ginger (Zingiber officinale) essential oils against Phytophthora colocasiae. Sci. Rep. 2022; 12, 2191.
KY Xi, SJ Xiong, G Li, CQ Guo, J Zhou, JW Ma, JL Yin, YQ Liu and YX Zhu. Antifungal activity of ginger rhizome extract against Fusarium solani. Horticulturae 2022; 8, 983.
M Mohammadi, SA Shahisaraee, A Tavajjohi, N Pournoori, S Muhammadnejad, SR Mohammadi, R Poursalehi and HH Delavari. Green synthesis of silver nanoparticles using Zingiber officinale and Thymus vulgaris extracts: Characterisation, cell cytotoxicity, and its antifungal activity against Candida albicans in comparison to fluconazole. IET Nanobiotechnology 2019; 13, 114-9.
MAA Mangoba and DG Alvindia. Potential use of Myrtus guajava (L.) Kuntze for the management of anthracnose disease of mango fruit. Indian Phytopathology 2023; 76, 133-40.
SB Nerilo, JCZ Romoli, LP Nakasugi, NS Zampieri, SAG Mossini, GHO Rocha, EMD Gloria, BADA Filho and M Machinski. Antifungal activity and inhibition of aflatoxins production by Zingiber officinale roscoe essential oil against Aspergillus flavus in stored maize grains. Ciência Rural 2020; 50, e20190779.
A Megawati and IS Wahyuni. Potential of herbal medicine in Asia for oral candidiasis therapy: A systematic review. Int. J. Appl. Pharmaceut. 2021; 13, 1-6.
AL Jayathilake, MA Jayasinghe and J Walpita. Development of ginger, turmeric oleoresins and pomegranate peel extracts incorporated pasteurized milk with pharmacologically important active compounds. Appl. Food Res. 2022; 2, 100063.
A Priya and SK Pandian. Piperine impedes biofilm formation and hyphal morphogenesis of Candida albicans. Front. Microbiol. 2020; 11, 756.
F Chaabane, A Graf, L Jequier and AT Coste. Review on antifungal resistance mechanisms in the emerging pathogen Candida auris. Front. Microbiol. 2019; 10, 2788.
HM Alkhalidi, KM Hosny and WY Rizg. Oral gel loaded by fluconazole-sesame oil nanotransfersomes: Development, optimization, and assessment of antifungal activity. Pharmaceutics 2021; 13, 27.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Walailak University
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
